Next Article in Journal
Mediterranean Basin Erica Species: Traditional Uses, Phytochemistry and Pharmacological Properties
Previous Article in Journal
Antioxidant and Antimicrobial Activities of Optimized Extract Obtained from Almond Shell Residues
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis and Properties of 1H-Pyrrolo[3′,2′:3,4]fluoreno[9,1-gh]quinolines and 7H-Pyrrolo[2′,3′,4′:4,10]anthra[1,9-fg]quinolines

Institut für Chemie, Universität Rostock, A.-Einstein-Str. 3a, 18059 Rostock, Germany
*
Authors to whom correspondence should be addressed.
Molecules 2025, 30(12), 2615; https://doi.org/10.3390/molecules30122615
Submission received: 25 April 2025 / Revised: 2 June 2025 / Accepted: 6 June 2025 / Published: 16 June 2025
(This article belongs to the Section Organic Chemistry)

Abstract

:
We report the synthesis of pyrrolo[3′,2′:3,4]fluoreno[9,1-gh]quinoline and pyrrolo[2′,3′,4′:4,10]anthra[1,9-fg]quinoline derivatives. This novel class of N-doped polycyclic heteroaromatic compounds was synthesized by a site-selective cross-coupling reaction followed by acid-mediated cycloisomerization and Pd-catalyzed CH arylation as the final ring-closing reactions. Preliminary optical and aromatic properties were studied by means of steady-state absorption and fluorescence spectroscopy and DFT calculation. Special emphasis was placed on the impact of ring alternation and position of the N-doping within the scaffold.

Graphical Abstract

1. Introduction

In the past, polycyclic aromatic compounds (PAHs) were merely known for their cancerogenic properties, which remain a subject of debate [1,2,3]. However, this class of compounds has nonetheless attracted widespread attention in the field of materials science [1,2,4,5,6,7,8]. These compounds offer unique (opto-)electronic properties accompanied by improved processability and tunability compared to their inorganic counterparts. Hence, PAH-based devices have been successfully applied as organic field-effect transistors (OFETs) [5,9,10,11], organic light-emitting diodes (OLEDs) [12,13,14], and organic photovoltaic cells (OPVs) [15,16,17].
The introduction of heteroatoms into the π-conjugated scaffold is an efficient strategy for altering the inherent properties of compounds and allows for the fine-tuning of their physical properties [18,19,20]. For instance, the incorporation of heteroatoms affects HOMO and LUMO energies and, consequently, optical and electrochemical properties and redox behavior. It influences coordination ability and acid–base chemistry, as well as bioactivity, to name but a few. In particular, nitrogen-containing PAHs have gained considerable attention due to their ability to change electronic properties depending on the nature of N-doping. The incorporation of imine-like N-atoms within the scaffold stabilizes the HOMO and LUMO energies, while amine-like nitrogen atoms improve the electron-donating properties of the polycyclic compound. Alternatively, alterations in ring size can influence the (opto-)electronic properties of PAHs and, hence, are a subject of intense research. For instance, the incorporation of five-membered rings can lead to unusual (photo-)physical properties and high electron affinities, similar to those of fullerene and its subunits. In addition, the incorporation of five-membered rings can lead to curved or bowl-shaped structures with intriguing properties, stemming from distorted orbital orientations [21,22,23,24].
As part of our ongoing interest in the synthesis of N-doped PAHs with alternating ring systems [25,26,27,28], we herein report the synthesis of pyrroloindeno- and pyrroloanthraquinoline derivatives. To the best of our knowledge, such structural motifs have not been described in the literature, and related carbocyclic PAHs are only rarely synthesized or detected as pollution components from domestic burning of coal and wood [29,30,31,32,33,34,35,36,37]. The synthetic strategy is based on the site-selective cross-coupling reaction of respective dibromopyridines followed by acid-mediated cycloisomerization. Pd-catalyzed CH arylation gives the final product in high yield [38].

2. Results and Discussion

Our synthesis started with the site-selective Sonogashira reactions of 2,3-dibromopyridine 1a and 3,4-dibromopyridine 1b. Both reactions proceeded selectively at position 2 or 4 of the pyridine ring, respectively, leaving position 3 of the pyridine ring untouched (Scheme 1). Subsequently, position 3 was substituted by the Suzuki–Miyaura reaction using N-methylindole-5-boronic acid pinacol ester, affording the arylated products in moderate yields. As a next step, we studied methanesulfonic acid (MsOH)-mediated cycloisomerization to synthesize indoloquinolines and indoloisoquinolines, respectively. The reaction proceeded smoothly but gave a mixture of isomers, which were separated by column chromatography. Both isomers were identified based on their specific H-H correlations determined by 1H-, COSY, and NOESY NMR experiments (for details, see SI). The employed reaction conditions led to the formation of 5a and 5b as major products. However, the yield of 4a was strongly diminished due to issues with its separation from 5a by column chromatography.
As a final step, we employed both isomers in palladium-catalyzed CH arylation, leading to the corresponding pyrrolo-fluorenoisoquinolines and pyrrolo-anthraisoquinolines. To elucidate suitable reaction conditions, PdCl2 was used in a first trial with PCy3 as the ligand, DBU as the base, and NMP as the solvent [38]. To our delight, the reaction worked very well, resulting in the desired products in good to excellent yields (Scheme 2). Hence, no further optimization of the reaction conditions was required.
Single crystals suitable for X-ray diffraction analysis were grown from a solution of 6a in dichloromethane and heptane (Figure 1 and Figure S1/Table S1). The molecular structure adopted an almost planar alignment, with deviations from planarity of about 3°and 4° in the two bay regions.
In the crystal lattice, two molecules orientate in opposite directions and form mutual close C-C contacts (3.38 Å and 3.30 Å) between the carbocyclic five-membered rings of the fluorene moiety and the benzene rings neighboring the pyrrole ring. Such dimers align in a herringbone-like pattern, and their respective stacks are stabilized by intermolecular C-H⋯C interactions.

3. Physical Properties

Compounds 6 and 7 were studied in terms of their optical and electrochemical properties. Steady-state absorption and photoluminescence spectra were obtained in dichloromethane solution, and the determined optical properties are shown in Table 1 and Figure 2. Compounds 6 and 7 exhibit similar absorption and emission features. Similarly, both classes show distinct fine-structured absorption spectra, with specific transitions for each class of compounds. Therefore, structural alteration results in differently structured absorption spectra, whereas the orientation of the pyridinic nitrogen within the polycyclic scaffold appears to have a negligible impact on the location and structure of the absorption and emission bands. In particular, compounds 6a and 6b show a distinctly red-shifted emission and reduced optical quantum yields compared to compounds 7. Interestingly, the orientation of the pyridinic nitrogen influences the quantum yields. While the quantum yield of compound 7a was 0.48, that of 7b was only 0.34. By contrast, no impact was detected for compounds 6, with a determined value of 0.10 for both derivatives.
Density Functional Theory (DFT) calculations [40] were carried out to improve our understanding of the electronic properties and aromaticity of the as-prepared compounds 6a,b and 7a,b. The calculated HOMO and LUMO energies are shown in Table 2 and Figure 3. The determined optical band gaps are generally smaller than the calculated values due to the exciton binding energy [41]. The electron density is distributed over the entire scaffold for all compounds. Compounds 6 have slightly reduced HOMO and LUMO, and a reduced band gap, as can be seen from their red-shifted absorption spectra compared to those of 7a and 7b. Compounds 6b and 7b have reduced HOMO and LUMO energies, possibly due to the different locations of the nitrogen atoms. Compound 6b has a slightly reduced band gap compared to 6a. Compounds 7a and 7b have the same calculated HOMO-LUMO gap, which could be explained by the nodal plane at the pyridinic nitrogen atom of 6a.
We also calculated the nucleus-independent chemical shifts (NICSs) and performed ring-current analyses as magnetic criteria of aromaticity to evaluate the aromatic properties of compounds 6 and 7 [42,43,44,45]. NICS(1.7)zz values and ring currents are almost independent of the nitrogen within the scaffold. Figure 4 exemplarily depicts the obtained NICS(1.7)zz data and corresponding ring currents for compounds 6a and 7a.
Based on the calculated negative NICS(1.7)zz values for all rings in both compounds, 6a and 7a can be classified as aromatic. However, the NICS(1.7)zz values of the connected rings C are significantly lower. This is corroborated by NICS2BC ring-current calculations. Compounds 6a and 7a possess a strong global diatropic ring current along their peripheries, as well as strong semi-global ring currents in their respective indoloquinoline moieties. Local ring currents are observed for ring D in both compounds. Rings C connects both (semi-)local ring currents but form no particular diatropic ring current, which explains their reduced aromaticity.

4. Experimental Section

General Information: The nuclear magnetic resonance spectra (1H/13C NMR) were recorded on a Bruker AVANCE 300 III, 250 II, or 500 (Bruker, Ettlingen, Germany). The analyzed chemical shifts δ were referenced to residual solvent signals of the deuterated solvent CDCl3 (δ = 7.26 ppm/77.16 ppm) or DMSO-d6 (δ = 2.50 ppm/39.52 ppm). Infrared spectra (IR) were measured in attenuated total reflection (ATR) experiments with a Nicolet 380 FT-IR spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). UV/Vis spectra were recorded on a Agilent Cary 60 UV–vis spectrophotometer, and emission spectra were recorded with an Agilent Cary Eclipse fluorescence spectrophotometer (Agilent Technologies, Santa Clara, CA, USA). Cyclovoltammetry (CV) was measured in CH3CN with 0.1 M nBu4NPF6 as the supporting electrolyte, a glassy carbon working electrode, ANE2 (Ag/AgNO3 0.01 M in CH3CN) as the reference electrode, and a Pt counter electrode with ferrocene as the external standard (1 mM in CH3CN). The potential is given vs. Fc+/Fc. The potentiostat used was a PalmSense EmStat3 blue (PalmSense, Houten, The Netherlands). Basic and high-resolution mass spectra (MS/HRMS) were measured on instruments paired with a preceding gas chromatograph (GC) or liquid chromatograph (LC). The samples were ionized through electron impact ionization (EI) on an Agilent 6890/5973 or Agilent 7890/5977 GC-MS equipped with an HP-5 capillary column using helium carrier gas or by applying electron spray ionization (ESI) on an Agilent 1200/6210 Time-of-Flight (TOF) LC–MS (Agilent Technologies, Santa Clara, CA, USA). The X-ray single-crystal structure analysis was performed on a Bruker Apex Kappa-II CCD diffractometer (Bruker AXS SE, Karlsruhe, Germany).
Materials: The applied solvents, 1,4-Dioxane, N-Methyl-2-pyrrolidone, DMA, and DCM, were obtained as dry solvents from commercial sources and employed without further purification. Solvents for extraction and column chromatography were available after previous distillation. If not otherwise stated, all reagents, such as 1-chloro-2-ethynylbenzene, (1-methyl-1H-indol-5-yl)boronic acid pinacol ester, methanesulfonic acid, catalysts, ligands, and bases, were purchased and used without further purification. Column chromatography was performed using a Merck Silica gel 60 (particle size 63–200 μm).
General Procedure for the Synthesis of 5-(2-((2-chlorophenyl)ethynyl)pyridin-3-yl)-1-methyl-1H-indole (3a) and 5-(4-((2-chlorophenyl)ethynyl)pyridin-3-yl)-1-methyl-1H-indole (3b):
To a glass pressure tube under an inert atmosphere were added 2 (250 mg, 1.0 equiv.), 2-Naphthaleneboronic acid (1.2 equiv.), Pd(PPh3)4 (5 mol%), K3PO4 (2.0 equiv.), and a mixture of 1,4-dioxane (6 mL) and H2O (1 mL). The reaction was heated in a metal block at 100 °C for 3 h. The solution was diluted with water and extracted with ethyl acetate three times, dried with sodium sulfate, and purified by column chromatography.
5-(2-((2-chlorophenyl)ethynyl)pyridin-3-yl)-1-methyl-1H-indole (3a). Starting with 2a (250 mg, 0.86 mmol), 3a was isolated as a yellow solid (183 mg, 62%); mp.: 112–114 °C. 1H NMR (500 MHz, Chloroform-d) δ 8.62 (dd, J = 4.7, 1.7 Hz, 1H), 7.99 (dd, J = 1.8, 0.7 Hz, 1H), 7.81 (dd, J = 7.8, 1.7 Hz, 1H), 7.54 (dd, J = 8.4, 1.8 Hz, 1H), 7.45 (dd, J = 7.7, 1.7 Hz, 1H), 7.40 (d, J = 8.4 Hz, 1H), 7.36–7.30 (m, 2H), 7.20 (td, J = 7.7, 1.8 Hz, 1H), 7.18–7.09 (m, 2H), 6.55 (dd, J = 3.2, 0.9 Hz, 1H), 3.83 (s, 3H). 13C{1H} NMR (126 MHz, Chloroform-d) δ 148.2, 141.5, 141.2, 137.6, 136.7, 136.4, 134.1, 129.7, 129.7, 129.3, 129.2, 128.6, 126.4, 123.3, 123.2, 122.9, 122.2, 109.2, 101.7, 94.0, 87.9, 33.1. MS (GC): m/z (%) = 345 (3), 344 (C22H1537ClN2, 13), 343 (13), 342 (M+, C22H1535ClN2, 38), 341 (11), 309 (3), 308 (27), 307 (100), 306 (11), 305 (8), 304 (2). HRMS (ESI-TOF) m/z: [M+H]+ calcd for C22H1535ClN2, 343.1002; found, 343.0999. IR (ATR): ṽ = 1618 (w), 1552 (w), 1475 (m), 1438 (m), 1416 (s), 1339 (m), 1249 (m), 1156 (w), 1076 (m), 1053 (m).
5-(4-((2-chlorophenyl)ethynyl)pyridin-3-yl)-1-methyl-1H-indole (3b). Starting with 2b (250 mg, 0.86 mmol), 3b was isolated as a yellow solid (159 mg, 54%); mp.: 84–86 °C. 1H NMR (500 MHz, Chloroform-d) δ 8.69 (s, 1H), 8.45 (d, J = 5.1 Hz, 1H), 7.91 (d, J = 1.0 Hz, 1H), 7.47 (dd, J = 8.5, 1.7 Hz, 1H), 7.44 (d, J = 5.1 Hz, 1H), 7.32 (d, J = 8.4 Hz, 1H), 7.28 (dd, J = 3.9, 1.5 Hz, 1H), 7.26 (dd, J = 4.3, 1.5 Hz, 1H), 7.17–7.12 (m, 1H), 7.07 (td, J = 7.6, 1.2 Hz, 1H), 7.01 (d, J = 3.1 Hz, 1H), 6.46 (dd, J = 3.0, 0.9 Hz, 1H), 3.74 (s, 3H). 13C{1H} NMR (126 MHz, Chloroform-d) δ 150.9, 147.2, 139.3, 136.7, 136.3, 133.8, 130.0, 129.7, 129.4, 129.1, 128.6, 128.0, 126.7, 126.5, 123.3, 122.7, 122.2, 109.3, 101.7, 92.7, 92.2, 33.1. MS (GC): m/z (%) = 345 (6), 344 (C22H1537ClN2, 27), 343(22), 342 (M+, C22H1535ClN2, 76), 341 (10), 340 (3), 309 (2), 308 (26), 307 (100), 306 (26), 305 (15), 304 (4). HRMS (ESI-TOF) m/z: [M+H]+ calcd for C22H1535ClN2, 343.1002; found, 343.0995. IR (ATR): ṽ = 1613 (w), 1578 (m), 1510 (m), 1484 (m), 1442 (m), 1397 (m), 1339 (m), 1245 (m), 1080 (m), 1055 (m).
General Procedure for the Synthesis of 6-(2-chlorophenyl)-8-methyl-8H-indolo[6,5-h]isoquinoline (4) and 4-(2-chlorophenyl)-1-methyl-1H-indolo[4,5-h]isoquinoline (5):
To a glass pressure tube under an inert atmosphere were added substances 3 (350 mg, 1 equiv.) and MsOH (30 equiv.). The reaction was carried out in a pressure tube and heated in a metal block at 120 °C for 18 h. Then, the cooled solution was diluted with ethyl acetate and extracted with saturated sodium bicarbonate 3 times, dried with sodium sulfate, and purified on a column.
6-(2-chlorophenyl)-8-methyl-8H-indolo[5,6-f]quinoline (4a). Starting with 3a (350 mg, 1.02 mmol), 4a was isolated as a yellow solid (38 mg, 11%); mp.: 198–200 °C. 1H NMR (250 MHz, Chloroform-d) δ 9.10–8.99 (m, 1H), 8.97 (s, 1H), 8.88 (dd, J = 4.4, 1.6 Hz, 1H), 7.74 (s, 1H), 7.62–7.41 (m, 5H), 7.33 (s, 1H), 7.24 (d, J = 3.6 Hz, 1H), 6.71 (dd, J = 3.2, 0.9 Hz, 1H), 3.73 (s, 3H). 13C{1H} NMR (63 MHz, Chloroform-d) δ 148.7, 147.3, 140.8, 139.7, 137.5, 134.2, 132.8, 132.1, 130.3, 129.9, 129.6, 129.3, 127.4, 127.0, 126.8, 126.7, 123.5, 121.4, 114.7, 105.4, 100.9, 33.2. MS (GC): m/z (%) = 345 (8), 344 (C22H1537ClN2, 34), 343 (26), 342 (M+, C22H1535ClN2, 100), 341 (2), 309 (2), 308 (17), 307 (72), 306 (11), 305 (14), 304 (3). HRMS (ESI-TOF) m/z: [M+H]+ calcd for C22H1535ClN2, 343.1002; found, 343.1000. IR (ATR): ṽ = 2920 (m), 1737 (w), 1620 (w), 1510 (m), 1461 (m), 1414 (m), 1374 (m), 1265 (m), 1082 (m), 1053 (m), 1032 (m).
6-(2-chlorophenyl)-8-methyl-8H-indolo[6,5-h]isoquinoline (4b). Starting with 3b (350 mg, 1.02 mmol), 4b was isolated as a yellow solid (109 mg, 31%); mp.: 103–105 °C. 1H NMR (300 MHz, Chloroform-d) δ 10.16 (s, 1H), 9.16 (s, 1H), 8.68 (s, 1H), 7.67 (d, J = 5.2 Hz, 1H), 7.64–7.59 (m, 1H), 7.51–7.43 (m, 4H), 7.35 (s, 1H), 7.30 (d, J = 3.2 Hz, 1H), 6.77 (dd, J = 3.2, 0.9 Hz, 1H), 3.75 (s, 3H). 13C{1H} NMR (63 MHz, Chloroform-d) δ 146.2, 144.6, 141.6, 139.6, 137.4, 134.6, 134.1, 133.1, 132.0, 130.0, 129.9, 129.5, 127.3, 127.0, 126.2, 124.1, 123.0, 121.3, 113.9, 105.7, 101.2, 33.2. MS (GC): m/z (%) = 345 (8), 344 (C22H1537ClN2, 33), 343 (24), 342 (M+, C22H1535ClN2, 100), 309 (2), 308 (18), 307 (74), 306 (9), 305 (11), 304 (3). HRMS (ESI-TOF) m/z: [M+H]+ calcd for C22H1535ClN2, 343.1002; found, 343.0997. IR (ATR): ṽ = 2922 (m), 1504 (m), 1461 (m), 1424 (s), 1414 (m), 1381 (m), 1337 (m), 1232 (s), 1053 (s), 1030 (m).
4-(2-chlorophenyl)-1-methyl-1H-indolo[5,4-f]quinoline (5a). Starting with 3a (350 mg, 1.02 mmol), 5a was isolated as a yellow solid (195 mg, 56%); mp.: 176–178 °C. 1H NMR (250 MHz, Chloroform-d) δ 9.04 (d, J = 9.2 Hz, 1H), 8.96 (dd, J = 4.3, 1.5 Hz, 1H), 8.56 (d, J = 9.1 Hz, 1H), 7.98 (d, J = 0.8 Hz, 1H), 7.70 (dd, J = 9.0, 0.9 Hz, 1H), 7.64–7.58 (m, 1H), 7.58–7.53 (m, 1H), 7.52–7.41 (m, 3H), 6.91 (d, J = 3.2 Hz, 1H), 5.35 (dd, J = 3.2, 0.9 Hz, 1H), 3.85 (s, 3H). 13C{1H} NMR (63 MHz, Chloroform-d) δ 149.0, 146.4, 141.8, 139.5, 135.4, 134.4, 131.5, 131.0, 129.8, 129.5, 129.2, 127.8, 127.2, 126.3, 125.3, 124.4, 124.0, 121.4, 117.2, 111.3, 102.7, 33.2. MS (GC): m/z (%) = 345 (3), 344 (C22H1537ClN2, 11), 343 (8), 342 (M+, C22H1535ClN2, 32), 341 (1), 309 (3), 308 (24), 307 (100), 306 (30), 305 (7), 304 (1). HRMS (ESI-TOF) m/z: [M+H]+ calcd for C22H1535ClN2, 343.1002; found, 343.1006. IR (ATR): ṽ = 2922 (w), 1576 (w), 1504 (w), 1469 (m), 1414 (m), 1346 (m), 1317 (m), 1261 (m), 1053 (m), 1032 (m).
4-(2-chlorophenyl)-1-methyl-1H-indolo[4,5-h]isoquinoline (5b). Starting with 3b (350 mg, 1.02 mmol), 5b was isolated as a yellow solid (168 mg, 48%); mp.: 180–182 °C. 1H NMR (250 MHz, Chloroform-d) δ 10.18 (s, 2H), 8.78 (d, J = 9.1 Hz, 1H), 8.68 (d, J = 5.4 Hz, 1H), 7.80–7.70 (m, 1H), 7.67–7.59 (m, 2H), 7.56–7.42 (m, 3H), 6.92 (d, J = 3.2 Hz, 1H), 5.33 (dd, J = 3.2, 0.9 Hz, 1H), 3.87 (s, 3H). 13C{1H} NMR (63 MHz, Chloroform-d) δ 147.3, 143.6, 141.7, 140.4, 135.4, 134.2, 133.7, 131.4, 129.8, 129.6, 127.9, 127.3, 126.1, 126.0, 125.9, 124.3, 124.1, 121.1, 116.4, 112.0, 102.6, 33.3. MS (GC): m/z (%) = 345 (2), 344 (C22H1537ClN2, 10), 343 (8), 342 (M+, C22H1535ClN2, 27), 341 (2), 309 (2), 308 (22), 307 (100), 306 (17), 305 (6), 304 (1). HRMS (ESI-TOF) m/z: [M+H]+ calcd for C22H1535ClN2, 343.1002; found, 343.1004. IR (ATR): ṽ = 1590 (vw), 1504 (w), 1414 (w), 1348 (w), 1304 (m), 1228 (vs), 1181 (s), 1121 (s), 1059 (m), 981 (s).
General Procedure for the Synthesis of 6 and 7:
To a pressure tube under an inert atmosphere were added 4 and 5 (53–120 mg, 1.0 equiv.), PdCl2 (0.2 equiv.), PCy3 (0.4 equiv.), DBU (3.0 equiv.), and NMP as a solvent. The reaction was carried out in a pressure tube and heated in a metal block at 150 °C for 18 h. The solution was diluted with distilled water and extracted three times with dichloromethane, then extracted five or six times with distilled water to remove the NMP. The organic layer was dried with sodium sulfate, filtered, and concentrated in vacuo. The residue was purified by column chromatography (heptane/EtOAc).
1-methyl-1H-pyrrolo[3′,2′:3,4]fluoreno[1,9-fg]quinoline (6a). Starting with 4a (53 mg, 0.15 mmol), 6a was isolated as a yellow solid (38 mg, 80%); mp.: 230–232 °C. 1H NMR (500 MHz, DMSO-d6) δ 9.28 (d, J = 8.2 Hz, 1H), 8.98 (dd, J = 15.2, 3.3 Hz, 2H), 8.61 (s, 1H), 8.53 (d, J = 7.8 Hz, 1H), 8.34 (d, J = 7.4 Hz, 1H), 7.72 (dd, J = 8.3, 4.3 Hz, 1H), 7.66 (d, J = 2.6 Hz, 1H), 7.51 (t, J = 7.5 Hz, 1H), 7.44 (t, J = 7.3 Hz, 1H), 6.88–6.83 (m, 1H), 4.49 (s, 3H). 13C{1H} NMR (126 MHz, DMSO-d6) δ 148.7, 148.2, 139.0, 137.7, 137.3, 135.2, 134.4, 133.5, 130.9, 128.9, 127.0, 126.0, 123.8, 122.7, 121.6, 120.6, 120.0, 117.5, 115.5, 102.5, 38.6. MS (GC): m/z (%) = 308 (3), 307 (24), 306 (M+, C22H14N2, 100), 305 (25), 304 (4), 303 (3). HRMS (ESI-TOF) m/z: [M+H]+ calcd for C22H15N2, 307.1235; found, 307.1232. IR (ATR): ṽ = 2920 (w), 1583 (w), 1527 (w), 1426 (m), 1401 (m), 1350 (m), 1315 (m), 1259 (s), 1080 (s), 1016 (s).
1-methyl-1H-pyrrolo[3′,2′:3,4]fluoreno[9,1-gh]isoquinoline (6b). Starting with 4b (73 mg, 0.21 mmol), 6b was isolated as a yellow solid (57 mg, 87%); mp.: 207–209 °C. 1H NMR (300 MHz, DMSO-d6) δ 10.15 (s, 1H), 9.03 (s, 1H), 8.70 (d, J = 5.4 Hz, 1H), 8.48–8.41 (m, 2H), 8.19 (dd, J = 7.2, 0.9 Hz, 1H), 8.00 (d, J = 4.7 Hz, 1H), 7.64 (d, J = 3.2 Hz, 1H), 7.45 (dtd, J = 22.7, 7.4, 1.2 Hz, 2H), 6.82 (d, J = 3.2 Hz, 1H), 4.43 (s, 3H). 13C{1H} NMR (75 MHz, DMSO-d6) δ 146.5, 144.4, 139.4, 138.1, 137.0, 135.6, 135.3, 134.7, 133.3, 129.1, 127.6, 126.0, 124.8, 123.8, 122.5, 122.3, 119.4, 117.7, 117.4, 114.8, 102.6, 39.2. MS (GC): m/z (%) = 308 (3), 307 (24), 306 (M+, C22H14N2, 100), 305 (27), 304 (6), 303 (2). HRMS (ESI-TOF) m/z: [M+H]+ calcd for C22H15N2, 307.1235; found, 307.1231. IR (ATR): ṽ = 2922 (m), 1595 (m), 1529 (m), 1447 (m), 1352 (m), 1317 (m), 1259 (m), 1199 (m), 1086 (s), 1016 (s).
7-methyl-7H-pyrrolo[2′,3′,4′:4,10]anthra[1,9-fg]quinoline (7a). Starting with 5a (120 mg, 0.35 mmol), 7a was isolated as a yellow solid (102 mg, 95%); mp.: 198–200 °C. 1H NMR (500 MHz, DMSO-d6) δ 9.29 (d, J = 6.9 Hz, 1H), 9.05 (dd, J = 4.1, 1.6 Hz, 1H), 9.00 (s, 1H), 8.85 (d, J = 7.9 Hz, 1H), 8.71 (d, J = 8.9 Hz, 1H), 8.22 (d, J = 11.9 Hz, 2H), 8.06 (d, J = 8.8 Hz, 1H), 7.71 (dd, J = 8.3, 4.2 Hz, 1H), 7.64 (t, J = 6.8 Hz, 1H), 7.58–7.53 (m, 1H), 4.19 (s, 3H). 13C{1H} NMR (126 MHz, DMSO-d6) δ 148.9, 146.6, 131.1, 130.8, 130.5, 129.6, 129.0, 128.7, 125.7, 125.5, 124.4, 123.7, 122.5, 122.2, 121.0, 120.9, 120.7, 119.3, 117.3, 112.3, 112.1, 33.7. MS (GC): m/z (%) = 308 (3), 307 (29), 306 (M+, C22H14N2, 100), 305 (16), 304 (3), 303 (2). HRMS (ESI-TOF) m/z: [M+H]+ calcd for C22H15N2, 307.1235; found, 307.1233. IR (ATR): ṽ = 1607 (w), 1529 (w), 1475 (w), 1418 (w), 1374 (m), 1350 (m), 1282 (w), 1230 (m), 1170 (w), 1043 (m).
1-methyl-1H-pyrrolo[2′,3′,4′:4,10]anthra[9,1-gh]isoquinoline (7b). Starting with 5b (95 mg, 0.28 mmol), 7b was isolated as a yellow solid (84 mg, 99%); mp.: 232–234 °C. 1H NMR (300 MHz, Chloroform-d) δ 10.01 (s, 1H), 8.67 (d, J = 5.5 Hz, 1H), 8.50 (dd, J = 8.1, 1.4 Hz, 1H), 8.44 (d, J = 8.9 Hz, 1H), 8.36 (s, 1H), 7.94 (dd, J = 7.8, 1.4 Hz, 1H), 7.83 (dd, J = 5.6, 0.9 Hz, 1H), 7.59–7.43 (m, 4H), 3.98 (s, 3H). 13C{1H} NMR (75 MHz, Chloroform-d) δ 146.6, 142.7, 134.4, 132.3, 130.8, 130.0, 129.4, 128.6, 125.5, 125.2, 124.2, 123.4, 122.6, 122.3, 122.1, 121.5, 120.3, 116.2, 116.2, 113.1, 111.4, 33.9. MS (GC): m/z (%) = 308 (3), 307 (20), 306 (M+, C22H14N2, 100), 305 (15), 304 (3), 303 (2). HRMS (ESI-TOF) m/z: [M+H]+ calcd for C22H15N2, 307.1235; found, 307.1237. IR (ATR): ṽ = 1607 (m), 1531 (m), 1453 (m), 1412 (m), 1372 (m), 1350 (m), 1224 (s), 1148 (m), 1039 (m).

5. Conclusions

Two isomers of each pyrrolo[3′,2′:3,4]fluoreno[9,1-gh]quinoline and pyrrolo [2′,3′,4′:4,10]anthra[1,9-fg]quinoline derivative were synthesized via cycloisomerization and Pd-catalyzed CH arylation with excellent yield. Despite the fluorescence quantum yields, the location of the nitrogen atom had a negligible impact on the optical and aromatic properties. However, altering the size of the central ring led to changes in the optical and aromatic properties of the polycyclic scaffold, highlighting the potential of bottom-up synthesis for the fine-tuning of respective properties.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules30122615/s1, Figure S1: ORTEPs of 4b, 5b and 6a; Figures S2–S27: NMR Spectra Table S1: Single crystal X-ray diffraction data; Tables S2–S5 Cartesian coordinates of the optimized ground-state (S0) structure 6a7b.

Author Contributions

Conceptualization, P.E. and P.L.; methodology, P.E.; software, P.E. and A.K.; validation, A.K. and P.E.; formal analysis, A.K. and A.V.; investigation, A.K.; resources, P.E.; data curation, A.K.; writing—original draft preparation, A.K.; writing—review and editing, P.E.; visualization, P.E.; supervision, P.E. and P.L.; project administration, P.E. and P.L.; funding acquisition, P.E. and P.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

The data underlying this study are available in the published article and its supporting information.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Peng, B.; Dong, Q.; Li, F.; Wang, T.; Qiu, X.; Zhu, T. A Systematic Review of Polycyclic Aromatic Hydrocarbon Derivatives: Occurrences, Levels, Biotransformation, Exposure Biomarkers, and Toxicity. Environ. Sci. Technol. 2023, 57, 15314–15335. [Google Scholar] [CrossRef] [PubMed]
  2. Abdel-Shafy, H.I.; Mansour, M.S. A review on polycyclic aromatic hydrocarbons: Source, environmental impact, effect on human health and remediation. Egypt. J. Pet. 2016, 25, 107–123. [Google Scholar] [CrossRef]
  3. Lin, C.; Huang, R.-J.; Duan, J.; Zhong, H.; Xu, W. Polycyclic aromatic hydrocarbons from cooking emissions. Sci. Total Environ. 2022, 818, 151700. [Google Scholar] [CrossRef]
  4. Keyte, I.J.; Harrison, R.M.; Lammel, G. Chemical reactivity and long-range transport potential of polycyclic aromatic hydrocarbons—A review. Chem. Soc. Rev. 2013, 42, 9333–9391. [Google Scholar] [CrossRef] [PubMed]
  5. Li, Q.; Zhang, Y.; Xie, Z.; Zhen, Y.; Hu, W.; Dong, H. Polycyclic aromatic hydrocarbon-based organic semiconductors: Ring-closing synthesis and optoelectronic properties. J. Mater. Chem. C 2022, 10, 2411–2430. [Google Scholar] [CrossRef]
  6. Goyal, H.; Kumar, P.; Gupta, R. Polycyclic Aromatic Hydrocarbon-based Soft Materials: Applications in Fluorescent Detection, Gelation, AIEE and Mechanochromism. Chem. Asian J. 2023, 18, e202300355. [Google Scholar] [CrossRef]
  7. Ball, M.; Zhong, Y.; Wu, Y.; Schenck, C.; Ng, F.; Steigerwald, M.; Xiao, S.; Nuckolls, C. Contorted polycyclic aromatics. Acc. Chem. Res. 2015, 48, 267–276. [Google Scholar] [CrossRef] [PubMed]
  8. Narita, A.; Wang, X.-Y.; Feng, X.; Müllen, K. New advances in nanographene chemistry. Chem. Soc. Rev. 2015, 44, 6616–6643. [Google Scholar] [CrossRef]
  9. Zhang, L.; Cao, Y.; Colella, N.S.; Liang, Y.; Brédas, J.-L.; Houk, K.N.; Briseno, A.L. Unconventional, chemically stable, and soluble two-dimensional angular polycyclic aromatic hydrocarbons: From molecular design to device applications. Acc. Chem. Res. 2015, 48, 500–509. [Google Scholar] [CrossRef]
  10. Kilaru, S.; Gade, R.; bhongiri, Y.; Tripathi, A.; Chetti, P.; Pola, S. Organic materials based on hetero polycyclic aromatic hydrocarbons for organic thin-film transistor applications. Mater. Sci. Semicond. Process. 2022, 147, 106730. [Google Scholar] [CrossRef]
  11. Wu, J. Polycyclic Aromatic Compounds for Organic Field-Effect Transistors:Molecular Design and Syntheses; Bentham Science Publishers: Sharjah, United Arab Emirates, 2007. [Google Scholar]
  12. Bauri, J.; Choudhary, R.B.; Mandal, G. Recent advances in efficient emissive materials-based OLED applications: A review. J. Mater. Sci. 2021, 56, 18837–18866. [Google Scholar] [CrossRef]
  13. Zhang, D.; Duan, L. Polycyclic Aromatic Hydrocarbon Derivatives toward Ideal Electron-Transporting Materials for Organic Light-Emitting Diodes. J. Phys. Chem. Lett. 2019, 10, 2528–2537. [Google Scholar] [CrossRef]
  14. Oner, S.; Bryce, M.R. A review of fused-ring carbazole derivatives as emitter and/or host materials in organic light emitting diode (OLED) applications. Mater. Chem. Front. 2023, 7, 4304–4338. [Google Scholar] [CrossRef]
  15. Aumaitre, C.; Morin, J.-F. Polycyclic Aromatic Hydrocarbons as Potential Building Blocks for Organic Solar Cells. Chem. Rec. 2019, 19, 1142–1154. [Google Scholar] [CrossRef]
  16. Yao, H.; Wang, J.; Xu, Y.; Zhang, S.; Hou, J. Recent Progress in Chlorinated Organic Photovoltaic Materials. Acc. Chem. Res. 2020, 53, 822–832. [Google Scholar] [CrossRef]
  17. Gu, X.; Luhman, W.A.; Yagodkin, E.; Holmes, R.J.; Douglas, C.J. Diarylindenotetracenes via a selective cross-coupling/C-H functionalization: Electron donors for organic photovoltaic cells. Org. Lett. 2012, 14, 1390–1393. [Google Scholar] [CrossRef] [PubMed]
  18. Borissov, A.; Maurya, Y.K.; Moshniaha, L.; Wong, W.-S.; Żyła-Karwowska, M.; Stępień, M. Recent Advances in Heterocyclic Nanographenes and Other Polycyclic Heteroaromatic Compounds. Chem. Rev. 2022, 122, 565–788. [Google Scholar] [CrossRef] [PubMed]
  19. Müller, M.; Ahrens, L.; Brosius, V.; Freudenberg, J.; Bunz, U.H.F. Unusual stabilization of larger acenes and heteroacenes. J. Mater. Chem. C 2019, 7, 14011–14034. [Google Scholar] [CrossRef]
  20. Liu, J.; Feng, X. Bottom-Up Synthesis of Nitrogen-Doped Polycyclic Aromatic Hydrocarbons. Synlett 2020, 31, 211–222. [Google Scholar] [CrossRef]
  21. Hou, X.-Q.; Sun, Y.-T.; Liu, L.; Wang, S.-T.; Geng, R.-L.; Shao, X.-F. Bowl-shaped conjugated polycycles. Chin. Chem. Lett. 2016, 27, 1166–1174. [Google Scholar] [CrossRef]
  22. Wu, Y.-T.; Siegel, J.S. Aromatic molecular-bowl hydrocarbons: Synthetic derivatives, their structures, and physical properties. Chem. Rev. 2006, 106, 4843–4867. [Google Scholar] [CrossRef] [PubMed]
  23. Chen, X.-L.; Yu, S.-Q.; Liang, J.-Q.; Huang, X.; Gong, H.-Y. Nitrogen-containing polycyclic aromatic hydrocarbons (PAHs) with bowl-shaped structures: Synthesis, architecture, and applications. Org. Chem. Front. 2025, 12, 1340–1354. [Google Scholar] [CrossRef]
  24. Wegner, H.A.; Reisch, H.; Rauch, K.; Demeter, A.; Zachariasse, K.A.; de Meijere, A.; Scott, L.T. Oligoindenopyrenes: A new class of polycyclic aromatics. J. Org. Chem. 2006, 71, 9080–9087, Correction in J. Org. Chem. 2007, 72, 1870. https://doi.org/10.1021/jo070008s. [Google Scholar] [CrossRef]
  25. Ausekle, E.; Ehlers, P.; Villinger, A.; Langer, P. Dibenzoindolo1,8naphthyridines: Synthesis and Characterization of X-Shaped Aza4,6helicenes. Chem. Eur. J. 2024, 30, e202303225. [Google Scholar] [CrossRef]
  26. Radolko, J.; Tuan, H.M.; Molenda, R.; Villinger, A.; Ehlers, P.; Langer, P. N-doped and Bowl-Shaped Azabenzo3,4azulenofluorene: Synthesis and Characterization of Bridged Aza-Triarylamines. Chem. Eur. J. 2024, 30, e202403004. [Google Scholar] [CrossRef] [PubMed]
  27. Spruner von Mertz, F.; Polkaehn, J.; Villinger, A.; Ehlers, P.; Langer, P. π-Expanded and N-Doped Fluoranthenes. J. Org. Chem. 2025, 90, 1024–1035. [Google Scholar] [CrossRef]
  28. Khomutetckaia, A.; Hildebrandt, N.; Ehlers, P.; Villinger, A.; Langer, P. Synthesis and Properties of Diindeno[1,2,3-cd:1′,2′,3′- mn ]pyrene and Two of Its Aza-Analogs. Eur. J. Org. Chem. 2024, 27, e202301101. [Google Scholar] [CrossRef]
  29. Lee, R.G.M.; Coleman, P.; Jones, J.L.; Jones, K.C.; Lohmann, R. Emission factors and importance of PCDD/Fs, PCBs, PCNs, PAHs and PM10 from the domestic burning of coal and wood in the U.K. Environ. Sci. Technol. 2005, 39, 1436–1447. [Google Scholar] [CrossRef]
  30. Schiedt, B. Über Dinaphthoperylen, zugleich ein Beitrag zur Chemie des Chrysens. Ber. dtsch. Chem. Ges. A/B 1938, 71, 1248–1253. [Google Scholar] [CrossRef]
  31. Clar, E. Neue Synthesen von Benzologen des Pyrens und Benzanthrens (Aromatische Kohlenwasserstoffe, XLI. Mitteil). Ber. dtsch. Chem. Ges. A/B 1943, 76, 609–621. [Google Scholar] [CrossRef]
  32. Zinke, A.; Zimmer, W. Untersuchungen über Perylen und seine Derivate. Monatsh. Chem. 1950, 81, 783–785. [Google Scholar] [CrossRef]
  33. Halton, B. Acephenanthrylenes from flash vacuum thermolysis of diarylmethylidenecycloproparenes. Tetrahedron Lett. 2006, 47, 1077–1079. [Google Scholar] [CrossRef]
  34. Cho, B.P.; Harvey, R.G. Polycyclic fluoranthene hydrocarbons. 2. A new general synthesis. J. Org. Chem. 1987, 52, 5668–5678. [Google Scholar] [CrossRef]
  35. Clar, E.; Stewart, D.G. 147. Aromatic hydrocarbons. Part LIX. 1: 2–3: 4-Dibenzpyrene. J. Chem. Soc. 1951; 687–690. [Google Scholar] [CrossRef]
  36. Lavit-Lamy, D.; Buu-Hoï, N.P. The true nature of “dibenzo[a,l]pyrene” and its known derivatives. Chem. Commun. 1966, 92–94. [Google Scholar] [CrossRef]
  37. Zander, M. Synthese von 1.2;3.4-Dibenzpyren und 1.2;4.5;8.9-Tribenzpyren. Chem. Ber. 1959, 92, 2749–2751. [Google Scholar] [CrossRef]
  38. Khomutetckaia, A.; Ehlers, P.; Villinger, A.; Langer, P. Synthesis and Properties of Azadibenzo[a,e]pyrenes. Eur. J. Org. Chem. 2024, 27, e202301299. [Google Scholar] [CrossRef]
  39. Brouwer, A.M. Standards for photoluminescence quantum yield measurements in solution (IUPAC Technical Report). Pure Appl. Chem. 2011, 83, 2213–2228. [Google Scholar] [CrossRef]
  40. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E. Gaussian 09; Gaussian, Inc.: Wallingford, CT, USA, 2013. [Google Scholar]
  41. Bredas, J.-L. Mind the gap! Mater. Horiz. 2014, 1, 17–19. [Google Scholar] [CrossRef]
  42. Stanger, A. NICS—Past and Present. Eur. J. Org. Chem. 2020, 2020, 3120–3127. [Google Scholar] [CrossRef]
  43. Gershoni-Poranne, R.; Stanger, A. Magnetic criteria of aromaticity. Chem. Soc. Rev. 2015, 44, 6597–6615. [Google Scholar] [CrossRef]
  44. Chen, Z.; Wannere, C.S.; Corminboeuf, C.; Puchta, R.; Schleyer, P.v.R. Nucleus-independent chemical shifts (NICS) as an aromaticity criterion. Chem. Rev. 2005, 105, 3842–3888. [Google Scholar] [CrossRef] [PubMed]
  45. Paenurk, E.; Gershoni-Poranne, R. Simple and efficient visualization of aromaticity: Bond currents calculated from NICS values. Phys. Chem. Chem. Phys. 2022, 24, 8631–8644. [Google Scholar] [CrossRef] [PubMed]
Scheme 1. Synthesis strategy for 1-methyl-1H-pyrrolo[3′,2′:3,4]fluoreno[9,1-gh]isoquinoline and 1-methyl-1H-pyrrolo[2′,3′,4′:4,10]anthra[9,1-gh]isoquinoline derivatives. Conditions: i (for 2a), 1a (1.0 equiv.), 1-Chloro-2-ethynylbenzene (1.2 equiv.), Pd(PPh3)4 (5 mol%), CuI (2 mol%), HNiPr2, 40 °C, 1 h; (for 2b), 1b (1.0 equiv.), 1-Chloro-2-ethynylbenzene (1.2 equiv.), Pd(PPh3)4 (10 mol%), CuI (10 mol%), HNiPr2, 40 °C, 3 h; ii, 2 (1.0 equiv.), 1-methyl-1H-indol-5-yl)boronic acid pinacol ester (1.2 equiv.), Pd(PPh3)4 (5 mol%), K3PO4 (2.0 equiv.), 1,4-dioxane/H2O (6:1), 100 °C, 3 h; iii, 3 (1.0 equiv.), MsOH (30 equiv.), 120 °C, 18 h.
Scheme 1. Synthesis strategy for 1-methyl-1H-pyrrolo[3′,2′:3,4]fluoreno[9,1-gh]isoquinoline and 1-methyl-1H-pyrrolo[2′,3′,4′:4,10]anthra[9,1-gh]isoquinoline derivatives. Conditions: i (for 2a), 1a (1.0 equiv.), 1-Chloro-2-ethynylbenzene (1.2 equiv.), Pd(PPh3)4 (5 mol%), CuI (2 mol%), HNiPr2, 40 °C, 1 h; (for 2b), 1b (1.0 equiv.), 1-Chloro-2-ethynylbenzene (1.2 equiv.), Pd(PPh3)4 (10 mol%), CuI (10 mol%), HNiPr2, 40 °C, 3 h; ii, 2 (1.0 equiv.), 1-methyl-1H-indol-5-yl)boronic acid pinacol ester (1.2 equiv.), Pd(PPh3)4 (5 mol%), K3PO4 (2.0 equiv.), 1,4-dioxane/H2O (6:1), 100 °C, 3 h; iii, 3 (1.0 equiv.), MsOH (30 equiv.), 120 °C, 18 h.
Molecules 30 02615 sch001
Scheme 2. Synthesis of 1-methyl-1H-pyrrolo[3′,2′:3,4]fluoreno[9,1-gh]isoquinoline (6) and 1-methyl-1H-pyrrolo[2′,3′,4′:4,10]anthra[9,1-gh]isoquinoline derivatives (7). Reaction conditions i: 4 or 5 (53–120 mg, 1.0 equiv.), PdCl2 (0.2 equiv.), PCy3 (0.4 equiv.), DBU (3.0 equiv.), NMP, 150 °C, 18 h.
Scheme 2. Synthesis of 1-methyl-1H-pyrrolo[3′,2′:3,4]fluoreno[9,1-gh]isoquinoline (6) and 1-methyl-1H-pyrrolo[2′,3′,4′:4,10]anthra[9,1-gh]isoquinoline derivatives (7). Reaction conditions i: 4 or 5 (53–120 mg, 1.0 equiv.), PdCl2 (0.2 equiv.), PCy3 (0.4 equiv.), DBU (3.0 equiv.), NMP, 150 °C, 18 h.
Molecules 30 02615 sch002
Figure 1. X-ray crystal structure of compound 6a. (Left): single-crystal structure of 6a; (Middle): formed dimers within the lattice with short C⋯C-contacts; (Right): herringbone-type alignment of dimers.
Figure 1. X-ray crystal structure of compound 6a. (Left): single-crystal structure of 6a; (Middle): formed dimers within the lattice with short C⋯C-contacts; (Right): herringbone-type alignment of dimers.
Molecules 30 02615 g001
Figure 2. Absorption (left) and emission (right) spectra of compounds 6a,b and 7a,b.
Figure 2. Absorption (left) and emission (right) spectra of compounds 6a,b and 7a,b.
Molecules 30 02615 g002
Figure 3. Visualization of HOMO and LUMO with associated energies.
Figure 3. Visualization of HOMO and LUMO with associated energies.
Molecules 30 02615 g003
Figure 4. NICS(1.7)zz and NICS2BC(1.25) ring currents of 6a and 7a.
Figure 4. NICS(1.7)zz and NICS2BC(1.25) ring currents of 6a and 7a.
Molecules 30 02615 g004
Table 1. Optical data of 6a,b and 7a,b.
Table 1. Optical data of 6a,b and 7a,b.
6a6b7a7b
λabs1 [nm]446446414418
(ε1 [a])0.150.150.280.31
λabs2 [nm]395395392397
(ε2 [a])0.220.220.280.30
λabs3 [nm]374374339393
(ε3 [a])0.210.210.230.22
λem1 [nm]519519500494
λem2 [nm]541 sh541 sh-509 sh
φ [%] [b]10104834
[a] [10–4 L mol–1 cm–1]; [b] fluorescence standard: coumarine 153 in EtOH (ϕ = 0.38) [39]; sh shoulder.
Table 2. Optical and DFT-calculated data for compounds 6 and 7.
Table 2. Optical and DFT-calculated data for compounds 6 and 7.
UV/visDFT
Egopt.
(eV) (a)
HOMODFT (eV) (b)LUMODFT (eV) (b)ΔEgDFT (eV)
6a2.62−5.41−2.053.36
6b2.62−5.49−2.193.30
7a2.90−5.24−1.743.50
7b2.90−5.35−1.853.50
(a) Estimated from the intersection of normalized absorption and emission spectra. (b) Calculated at the B3LYP/6-311G(d, p) level of theory.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Khomutetckaia, A.; Ehlers, P.; Villinger, A.; Langer, P. Synthesis and Properties of 1H-Pyrrolo[3′,2′:3,4]fluoreno[9,1-gh]quinolines and 7H-Pyrrolo[2′,3′,4′:4,10]anthra[1,9-fg]quinolines. Molecules 2025, 30, 2615. https://doi.org/10.3390/molecules30122615

AMA Style

Khomutetckaia A, Ehlers P, Villinger A, Langer P. Synthesis and Properties of 1H-Pyrrolo[3′,2′:3,4]fluoreno[9,1-gh]quinolines and 7H-Pyrrolo[2′,3′,4′:4,10]anthra[1,9-fg]quinolines. Molecules. 2025; 30(12):2615. https://doi.org/10.3390/molecules30122615

Chicago/Turabian Style

Khomutetckaia, Aleksandra, Peter Ehlers, Alexander Villinger, and Peter Langer. 2025. "Synthesis and Properties of 1H-Pyrrolo[3′,2′:3,4]fluoreno[9,1-gh]quinolines and 7H-Pyrrolo[2′,3′,4′:4,10]anthra[1,9-fg]quinolines" Molecules 30, no. 12: 2615. https://doi.org/10.3390/molecules30122615

APA Style

Khomutetckaia, A., Ehlers, P., Villinger, A., & Langer, P. (2025). Synthesis and Properties of 1H-Pyrrolo[3′,2′:3,4]fluoreno[9,1-gh]quinolines and 7H-Pyrrolo[2′,3′,4′:4,10]anthra[1,9-fg]quinolines. Molecules, 30(12), 2615. https://doi.org/10.3390/molecules30122615

Article Metrics

Back to TopTop